In COVID-19, SARS-CoV-2 may bind testicle ACE2, leading to Sertoli and Leydig cells’ damage with subsequent inhibition of testicular testosterone synthesis (Illiano et al., 2020). This evidence concerns the gene ACE2 and COVID-19.